This consensus protocol outlines standardized pre- and post-procedure skincare practices designed to optimize treatment outcomes, enhance skin recovery, and minimize complications following aesthetic procedures. It provides evidence-based guidance for skin preparation before treatment and structured aftercare to support healing, reduce inflammation, prevent infection, and maintain long-term results.
This protocol presents a Delphi-based expert consensus on standardized pre- and post-procedure skincare for aesthetic treatments, developed to optimize clinical outcomes, enhance patient safety, and minimize procedure-related complications. The recommendations apply to a broad spectrum of aesthetic interventions, including injectables, laser and energy-based devices, chemical peels, microneedling, and combination therapies. Consensus Development Methodology (Delphi Method) This protocol is developed using the Delphi method, a structured, iterative process designed to achieve expert agreement through multiple rounds of anonymous feedback. A multidisciplinary panel of experienced aesthetic physicians, dermatologists, and skincare experts participates in sequential survey rounds. Each round refines key recommendations based on: * Aggregated expert responses * Controlled feedback * Statistical agreement thresholds This approach ensures that the final protocol reflects high-level expert agreement, minimizes bias, and supports evidence-informed clinical decision-making.
Study Type
OBSERVATIONAL
Enrollment
15
Venus Research Center
Cairo, Egypt
Level of Expert Consensus on Pre- and Post-Procedure Skincare Protocols for Aesthetic Procedures
The primary outcomes of this Delphi study are the levels of expert consensus on recommended pre- and post-procedure skincare protocols across various aesthetic procedures. Specifically, the study aims to determine expert agreement on: (1) pre-procedure skin preparation measures, including barrier optimization, hydration, photoprotection, and any topical priming agents; (2) post-procedure care, including barrier repair, management of erythema or inflammation, photoprotection, and timing for reintroduction of active topical agents
Time frame: 6-8 weeks
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.